ACC.20/WCC Virtual Meeting Begins Saturday, March 28, 2020

The American College of Cardiology annual scientific sessions planned for March 28-30, 2020 at McCormick Place in Chicago have been rescheduled to convene in the comfort of homes throughout the world.

ACC.20/WCC Virtual begins on Saturday, March 28, at 8 am CDT (1 pm GMT) and is offering 4 hours of live education each day to include Late-Breaking Clinical Trials, Featured Clinical Research, Young Investigator Awards, Keynotes, and more.

No advanced registration needed – only your desktop, laptop, notebook, smart phone or other device to access the meeting page at https://virtual.acc.org and begin watching the sessions.

Because the COVID-19 situation is causing unprecedented disruption across the healthcare community, it is likely that some who had planned to participate in the virtual activities may be unable to join them during the scheduled times.

______________________________________________

All live ACC.20/WCC Virtual sessions will be made available on demand along with access to more videos, abstracts, and other meeting materials for at least 90 days after the meeting. There will be no charge for tapping into this cache of science and expert insight.

______________________________________________

The ACC.20/WCC Virtual will being on Saturday morning, March 28,  8 am CDT (1 p.m. GMT) with the ACC.20/WCC Virtual Opening Showcase Session, followed by the first Late-Breaking Clinical Trial Session.

PREVIEW

Saturday Morning Late Breakers – Joint American College of Cardiology and Journal of the American College of Cardiology Late-Breaking Clinical Trials I

9:00 - 10:00 am CT

9:00 – 9:12The VICTORIA (Vericiguat Global Study In Subjects With Heart Failure With Reduced Ejection Fraction) Trial  9:20 - 9:32  Rivaroxaban for Prevention Of Cardiovascular And Limb Events After Lower Extremity Revascularization: Primary Results Of The VOYAGER PAD  Randomized Trial 9:40 AM - 9:52Clinical Implementation of Clopidogrel Pharmacogenetics: The TAILOR PCI Trial

Panel discussions will include Drs. Clyde Yancy and Valentin Fuster
    ___________________________________

Sunday Morning Late Breakers - Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials II
8:00 – 9:15 am CT

• Antithrombotic Therapy After Transcatheter Aortic Valve Implantation In Patients With A Long-term Indication For Oral Anticoagulation (POPular TAVI Trial - Cohort B)

• Transcatheter Aortic Valve Replacement In Patients With Severe Bicuspid Aortic Valve Stenosis At Low Predicted Risk Of Mortality

• A Composite Metric For Benchmarking Site Performance In Transcatheter Aortic Valve Replacement: Results From The STS/ACC TVT Registry
  ___________________________________

Monday Morning Late Breakers IV 
8:00 - 9:30 am CT

• Ticagrelor With Or Without Aspirin In Acute Coronary Syndrome After Percutaneous Coronary Intervention: Randomized Evaluation Of Ticagrelor Monotherapy After 3-month Dual-antiplatelet Therapy In Acute Coronary Syndrome

• Safety And Efficacy Of Ticagrelor Monotherapy After Complex PCI: The TWILIGHT-COMPLEX Substudy 

• Ticagrelor With And Without Aspirin In High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: Insights From The TWILIGHT Trial

    ___________________________________

Learn more about ACC.20/WCC Virtual and view the full schedule of live and on demand education.